Zhun Cao, PhD
Articles
January 16th 2012
Impact of Cost-Sharing on Treatment Augmentation in Patients With Depression
Teresa B. Gibson, PhD Yonghua Jing, PhD Jill E. Bagalman, MSW Zhun Cao, PhD John A. Bates, PhD Tony Hebden, PhD Robert A. Forbes, PhD Jalpa A. Doshi, PhD
Higher patient cost-sharing is associated with a lower likelihood of treatment augmentation in patients with depression who are treated with antidepressants.
June 10th 2010
Jay M. Margolis, PharmD Zhun Cao, PhD Eberechukwu Onukwugha, PhD Robert J. Sanchez, MS Jose Alvir, DrPH Ashish V. Joshi, PhD C. Daniel Mullins, PhD
Prior authorization for pregabalin in commercial insurance plans accomplished the objective of lower pregabalin utilization; however, there was no significant decrease in disease-related healthcare costs.
Latest Updated Articles
Published: January 16th 2025 | Updated: January 29th 2025
FDA Proposal Aims to Reduce Smoking Addiction and SCLC Cases
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
